All Publications

S. Chahal, A. Debnath, R. Kumari, P. Ridhal, R. K. Sahoo, B. K. Biswal, P. Siwach, and A. Mishra,"Antihypertensive potential of diosgenin: A comparative pharmacoinformatics study", Computers in Biology and Medicine, vol.196, no.part c, Elsevier 2025, 10.1016/j.compbiomed.2025.110911. Epub 2025 Aug 13       Article

R. K. Sahoo, S. K. Tripathi, K. Barik, S. Biswal, S. K. Patra, S. S. Panda, A. Kumar, and B. K. Biswal,"Piperlongumine triggers reactive oxygen species driven mitochondrial dysfunction leading to apoptosis in human colon cancer cells", Biofactors, vol.51, no.6, Wiley, November 2025, 10.1002/biof.70050       Article

R. K. Sahoo, Z. A. Ansari, S. K. Pradhan, and B. K. Biswal,"Integrative computational and experimental validation of Piperlongumine as a therapeutic agent targeting differentially expressed genes in colorectal cancer", Pathology -Research and Practice, vol.275, no.156243, Elsevier, November 2025, 10.1016/j.prp.2025.156243       Article

S. K. Patra, S. K. Pradhan, Z. A. Ansari, and B. K. Biswal,"Investigating therapeutic potential of evodiamine by identifying differentially expressed genes in cisplatin resistance non-small cell lung cancer", Medical Oncology, vol.43, no.42, Springer, December 2025, 10.1007/s12032-025-03178-2       Article

S. Biswal, R. K. Sahoo, S. K. Patra, S. S. Panda, and B. K. Biswal,"Epigenetic drug discovery in multiresistant cancers and autoimmune diseases", Epigenetic Drug Discovery Advancements, Challenges, and Applications in Precision Medicine, ch.5, pp.256, CRC Press, September 2025, 10.1201/9781032706511-5       Inbook

S. K. Tripathi, R. K. Sahoo, and B. K. Biswal,"Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells", Naunyn-Schmiedeberg's Archives of Pharmacology, Springer, January 2024, https://doi.org/10.1007/s00210-024-02965-4       Article

M. Panda, S. Biswal, and B. K. Biswal,"Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-ß-catenin axis", Molecular Biology Reports, vol.51, Springer, April 2024, https://doi.org/10.1007/s11033-024-09477-7       Article

R. K. Sahoo, S. K. Tripathi, S. Biswal, M. Panda, A. S. Mathapati, and B. K. Biswal,"Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics", Biotechnology Journal, Wiley, January 2024, DOI: 10.1002/biot.202300370       Article

S. K. Patra, R. K. Sahoo, S. Biswal, S. S. Panda, and B. K. Biswal,"Enigmatic Exosomal Connection in Lung Cancer Drug Resistance", Molecular Therapy-Nucleic Acids, vol.35, Cell Press, March 2024, https://doi.org/10.1016/j.omtn.2024.102177       Article

S. S. Panda, R. K. Sahoo, S. K. Patra, S. Biswal, and B. K. Biswal,"Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance", Drug Discovery Today, Elsevier, June 2024, https://doi.org/10.1016/j.drudis.2024.104061       Article